EQIX
50
3
DNB
36
2
DE
29
-3
PM
52
-4
LYB
32
2
GIS
54
2
MDLZ
36
4
MHK
40
-6
ICE
67
3
PAYX
56
2
SYF
83
-3
HD
57
3
MU
43
-4
TRV
43
-3
PEG
41
-3
MAT
50
18
SLG
71
-4
F
42
-4
WU
24
-6
HAL
41
11
EQIX
50
3
DNB
36
2
DE
29
-3
PM
52
-4
LYB
32
2
GIS
54
2
MDLZ
36
4
MHK
40
-6
ICE
67
3
PAYX
56
2
SYF
83
-3
HD
57
3
MU
43
-4
TRV
43
-3
PEG
41
-3
MAT
50
18
SLG
71
-4
F
42
-4
WU
24
-6
HAL
41
11
Financhill
Back

First Trust Indxx Glbl Natrl ResETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
41

FTRI
First Trust Indxx Glbl Natrl ResETF

Last Price:
13.05
Seasonality Move:
-0.18%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
41
First Trust Indxx Glbl Natrl ResETF (FTRI) is a Sell

Is First Trust Indxx Glbl Natrl ResETF a Buy, Sell or Hold?

  • The current First Trust Indxx Glbl Natrl ResETF [FTRI] share price is $13.07. The Score for FTRI is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • FTRI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FTRI Stock Price Chart

What is First Trust Indxx Glbl Natrl ResETF's stock price today?

  • The First Trust Indxx Glbl Natrl ResETF share price today is $13.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTRI is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

FTRI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 41.2 Sell
Chaikin Money Flow: 6412 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.13 - 13.83) Sell
Bollinger Bands (100): (12.61 - 13.65) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

FTRI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.07 Buy
20-day SMA: 13.37 Sell
50-day SMA: 13.51 Sell
200-day SMA: 12.9 Buy
8-day EMA: 13.12 Sell
20-day EMA: 13.3 Sell
50-day EMA: 13.37 Sell
200-day EMA: 13.09 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

First Trust Indxx Glbl Natrl ResETF Earnings Growth & FTRI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

First Trust Indxx Glbl Natrl ResETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):